Authors


Robert W. Maltby

Latest:

Explore Ovarian Cancer Treatments Through Clinical Trials

Guidelines typically recommend debulking surgery, plus systemic chemotherapy for most patients.


Grace Morrison, PharmD Candidate

Latest:

Denosumab With Ovarian Function Suppression and Aromatase Inhibitor Therapy in ER-Positive, Early-Stage Breast Cancer

In premenopausal women, denosumab significantly prevented bone loss and microarchitectural deterioration.


Michelle Phillips, PharmD, BCOP

Latest:

Brown Bag Consult®: A Patient With Colorectal Cancer Seeks Counsel From a Pharmacist

The patient's list of medications reveals significant drug interactions to be addressed.


Maryam Akintoye, PharmD Candidate

Latest:

A Pharmacist’s Guide to the Management of Polycystic Ovarian Syndrome

Pharmacists play an important role in managing patients with this complex condition.


Jennie Reese, PharmD Candidate 2023

Latest:

Commonly Overlooked Adverse Effects in the Community, Clinical Pharmacy Settings

Although pharmacists possess a wealth of knowledge on AEs, it remains a monumental task to recall the clinical significance of every AE, even with the most commonly used medications.


Christian Olsen

Latest:

Integrated Multi-Omic Data: Powering Precision Medicine

Through increased utilization of multi-omic data, health care professionals can revolutionize the treatment paradigm of countless diseases.



Laura Momoko Asakura, PharmD, BCOP, BCSPS

Latest:

ASCO 2025: Oncology Pathway Tools Show Consistent Usage Across Patient Groups

Laura Momoko Asakura, PharmD, BCOP, BCSPS, discusses the equitable use of oncology treatment pathway tools, highlighting that their utilization remains consistent across patient groups regardless of race, ethnicity, or insurance status.


Frances M. Colón-Pratts, PharmD, CDCES

Latest:

Improving Vaccination Rates Among Adults and Young Adults

Myths, fears, distrust, and misinformation on immunizations can keep patients from benefiting from their protective effects.


Ada Griffin, PharmD Candidate

Latest:

Melanoma Armamentarium Progresses Toward Precision Therapy

Novel drug development has been focused on the augmentation of the T-lymphocyte response.


Matthew Gavidia

Latest:

Expert: Burnout in Oncology Pharmacy May Be a Result of Issues Relating to Onboarding, Training of New Employees

Elizabeth Spurlock, MA, PHR, director of HR Business Partner at Texas Oncology, discusses how burnout among physicians, nurses, and hospital administrators has impacted the role of the pharmacist in patient care.


Megan May, PharmD, BCOP, FHOPA, FAPO

Latest:

Real-World Data on Expanding Step-Up Dosing Administration of Bispecific T-Cell Engagers in the Outpatient Setting

This abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025.



Andrew Skinner, MD

Latest:

Key Takeaways on FMTs in the Treatment of CDI

Experts provide practice pearls for educating patients on and using FMTs for the management of CDI.


Andrew Straw, PharmD, BCADM

Latest:

Student Advocacy and Its Impact on Tobacco Cessation Programs

Because pharmacists are one of the most accessible health care providers, we are trained in medication selection and in how to counsel patients who wish to stop smoking.


Krista D. Capehart, PharmD, BCACP, FAPhA

Latest:

Closing Thoughts From The Panel On Pneumococcal Vaccination

The panel of pneumococcal vaccination experts offer their concluding insights and perspectives on the current landscape of pneumococcal vaccines.



Dena Homayounieh, PharmD, MSc

Latest:

Case Study: Insulin Sensitizers as Enhancers in Diabetes Management

The objective of this study is to evaluate the use of low-dose pioglitazone, without relying on high doses of insulin, by enhancing sensitivity as a suitable, cost-effective strategy compared to larger insulin doses in patients with limited access to care.


Paul Feuerstadt, MD, FACG, AGAF

Latest:

Advice for Physicians to Manage C. Difficile Infection (CDI)

Experts share advice for physicians taking care of patients with C. difficile infection (CDI).


David Webster, MSBA, BPharm

Latest:

Regulations Guiding Sterile Compounding Are Complex

Understanding the categories is key to evaluating and making decisions about outsourcing products or improving internal production standards.


Sue Ojageer, PharmD

Latest:

Color a Career: Pharmacy Coloring Book Features Traditional, Nontraditional Roles

Coloring can be a form of mindfulness and promotes relaxation and reduces stress, which is particularly valuable in the fast-paced world of health care.


Ryan W. Stevens, PharmD, BCIDP (SIDP)

Latest:

Outpatient ASPs Are Worth the Journey

Developing an antimicrobial stewardship program is arduous but valuable; commitment from leadership is the first step.


Corey Medler, PharmD

Latest:

Improve Care for Patients With Community-Acquired Pneumonia

Empiric anti-MRSA therapy is an area of opportunity for antimicrobial stewardship in the treatment of CAP.


Pranav Patel, PharmD, MS

Latest:

A Primer for Medical Specialty Drug Utilization Management Strategies

Case management programs or pharmacist-delivered high-touch care are critical components in medical specialty drug management.


Meina Determan, PharmD Candidate

Latest:

Menstrual Migraines: Overview, Treatment, and Prevention

Pharmacists play a key role in migraine management, therefore, awareness of menstrual migraine-specific prophylaxis is important.


Christopher Svetcov, PharmD

Latest:

Vax-Innovation: Incorporating the Newly Approved RSV and Pneumococcal Vaccines Into Community Pharmacy Workflow

Best practices to train staff and team members to engage patients and to ease the new vaccine offerings into the workflow are also discussed.


Jeremiah Moore, PharmD, BCOP

Latest:

Multiple Myeloma Therapy Often Causes Cardiovascular Complications

Many patients have baseline risk factors present at diagnosis because of older age and disease-related elements.


Jose Tinajero, PharmD, BCOP

Latest:

Sequencing of Liposomal Daunorubicin/Cytarabine Versus Hypomethylating Agents Plus Venetoclax for Secondary Acute Myeloid Leukemia

This abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025.


Jennifer Goldman, PharmD, CDES, BC-ADM, FCCP

Latest:

Pharmacists Have a Crucial Role Helping Patients With ATTR-CM Navigate Treatment With Tafamidis

Pharmacists can help oversee the treatment process to ensure patients with transthyretin amyloid cardiomyopathy (ATTR-CM) are adhering to tafamidis.


Erin Venable

Latest:

NHA Helping Pharmacy Technicians With Soft Skills; No Longer a Tall Order

From certified medical assistants to phlebotomy technicians, the need for positive patient-provider interactions has proven critical both in achieving high patient satisfaction rates and improving patient experience.